Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Molina Healthcare, a key player in the managed care sector, reported a third-quarter 2025 performance with an adjusted EPS of $1.84 and premium revenues amounting to $10.8 billion.</li><li>Despite meticulous effort, these results fell short of expectations, largely due to persistent challenges in medical cost management within their Marketplace segment and pressures in Medicaid.</li><li>Throughout the quarter, Molina faced elevated medical cost trends across various areas including behavioral health, pharmacy, long-term services and supports (LTSS), and inpatient care, culminating in a consolidated medical care ratio (MCR) of 92.6%.</li></ul>

Molina Healthcare, a key player in the managed care sector, reported a third-quarter 2025 performance with an adjusted EPS of $1.84 and premium revenues amounting to $10.8 billion.Despite meticulous effort, these results fell short of expectations, largely due to persistent challenges in medical cost management within their Marketplace segment and pressures in Medicaid.Throughout the quarter, Molina faced elevated medical cost trends across various areas including behavioral health, pharmacy, long-term services and supports (LTSS), and inpatient care, culminating in a consolidated medical care ratio (MCR) of 92.6%.

몰리나 헬스케어, 수익성 회복을 위한 강력한 메디케이드 수가 인상 계획 발표!